J&J Adds Mortality Risk to Heart Drug Label (Reuters)


Reuters - Johnson & Johnson has revised the
label of its Natrecor heart failure medicine to include data
that suggest it may increase the risk of death, following two
widely publicized medical journal articles that questioned its
safety.

Read more...